Physician profile
Marnee Spierer
NPI 1033290465
$638.75
in general payments reported to CMS, 2019-2025
12 companies · $269 in 2025
The $269 reported for 2025 was more than what a typical Radiation Oncology provider received nationally (typical 2025 total: $172).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $129 · 2020: $114 · 2022: $19.18 · 2024: $108 · 2025: $269.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $377.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $376.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Siemens Medical Solutions USA, INC. | $146.91 | 2022-2025 | Varian Ethos Treatment Planning |
| Varian Medical Systems, INC. | $114.34 | 2019-2020 | |
| Lilly USA, LLC | $105.32 | 2019 | |
| Incyte Corporation | $46.28 | 2024-2025 | Pemazyre, Monjuvi, Jakafi |
| Novartis Pharmaceuticals Corporation | $37.78 | 2025 | |
| Teleflex LLC | $36.61 | 2025 | Barrigel |
| Regeneron Healthcare Solutions, INC. | $29.05 | 2024 | Libtayo |
| Pharmacosmos Therapeutics INC. | $26.10 | 2024 | Monoferric |
| Angiodynamics, INC. | $25.02 | 2024 | Nanoknife |
| Astrazeneca Pharmaceuticals LP | $24.08 | 2025 | Imfinzi |
| Boston Scientific Corporation | $23.90 | 2025 | Spaceoar Vue System - 10ml |
| Bayer Healthcare Pharmaceuticals INC. | $23.36 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Marnee Spierer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.